Restoration of c-Src/Fyn Proteins Rescues Mitochondrial Dysfunction in Huntington's Disease

被引:8
|
作者
Fao, Ligia [1 ,2 ]
Coelho, Patricia [1 ]
Duarte, Luis [1 ]
Vilaca, Rita [1 ,3 ]
Hayden, Michael R. [4 ]
Mota, Sandra I. [1 ,3 ]
Rego, Ana Cristina [1 ,2 ,5 ]
机构
[1] Univ Coimbra, Ctr Neurosci & Cell Biol CNC, Coimbra, Portugal
[2] Univ Coimbra, Fac Med, Coimbra, Portugal
[3] Univ Coimbra, Inst Interdisciplinary Res IIIUC, Coimbra, Portugal
[4] Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC, Canada
[5] Univ Coimbra, Ctr Neurosci & Cell Biol CNC, Polo 1 Rua Larga, P-3004504 Coimbra, Portugal
关键词
Src kinase; Fyn kinase; mutant huntingtin; mitochondria; Huntington disease; autophagy; MUTANT HUNTINGTIN; TYROSINE PHOSPHORYLATION; IN-VITRO; KINASE; AUTOPHAGY; NEURODEGENERATION; ACTIVATION; MECHANISM; MUTATION; SYSTEM;
D O I
10.1089/ars.2022.0001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aims: Huntington's disease (HD) is an autosomal-dominant neurodegenerative disorder with no effective therapies. Mutant huntingtin protein (mHTT), the main HD proteinaceous hallmark, has been linked to reactive oxygen species (ROS) formation and mitochondrial dysfunction, among other pathological mechanisms. Importantly, Src-related kinases, c-Src and Fyn, are activated by ROS and regulate mitochondrial activity. However, c-Src/Fyn involvement in HD is largely unexplored. Thus, in this study, we aimed at exploring changes in Src/Fyn proteins in HD models and their role in defining altered mitochondrial function and dynamics and redox regulation.Results: We show, for the first time, that c-Src/Fyn phosphorylation/activation and proteins levels are decreased in several human and mouse HD models mainly due to autophagy degradation, concomitantly with mHtt-expressing cells showing enhanced TFEB-mediated autophagy induction and autophagy flux. c-Src/Fyn co-localization with mitochondria is also reduced. Importantly, the expression of constitutive active c-Src/Fyn to restore active Src kinase family (SKF) levels improves mitochondrial morphology and function, namely through improved mitochondrial transmembrane potential, mitochondrial basal respiration, and ATP production, but it did not affect mitophagy. In addition, constitutive active c-Src/Fyn expression diminishes the levels of reactive species in cells expressing mHTT.Innovation: This work supports a relevant role for c-Src/Fyn proteins in controlling mitochondrial function and redox regulation in HD, revealing a potential HD therapeutic target.Conclusion: c-Src/Fyn restoration in HD improves mitochondrial morphology and function, precluding the rise in oxidant species and cell death.
引用
收藏
页码:95 / 114
页数:20
相关论文
共 50 条
  • [31] Distinct Roles for N-Cadherin Linked c-Src and Fyn Kinases in Lens Development
    Leonard, Michelle
    Zhang, Liping
    Bleaken, Brigid M.
    Menko, A. Sue
    DEVELOPMENTAL DYNAMICS, 2013, 242 (05) : 469 - 484
  • [32] Bypassing mitochondrial defects rescues Huntington's phenotypes in Drosophila
    Campesan, Susanna
    del Popolo, Ivana
    Marcou, Kyriaki
    Straatman-Iwanowska, Anna
    Repici, Mariaelena
    Boytcheva, Kalina, V
    Cotton, Victoria E.
    Allcock, Natalie
    Rosato, Ezio
    Kyriacou, Charalambos P.
    Giorgini, Flaviano
    NEUROBIOLOGY OF DISEASE, 2023, 185
  • [33] Mitochondrial c-Src regulates cell survival through phosphorylation of respiratory chain components
    Ogura, Masato
    Yamaki, Junko
    Homma, Miwako K.
    Homma, Yoshimi
    BIOCHEMICAL JOURNAL, 2012, 447 : 281 - 289
  • [34] Potassium channel dysfunction in neurons and astrocytes in Huntington's disease
    Zhang, Xiao
    Wan, Jie-Qing
    Tong, Xiao-Ping
    CNS NEUROSCIENCE & THERAPEUTICS, 2018, 24 (04) : 311 - 318
  • [35] Histone Deacetylase Inhibitors Protect Against Pyruvate Dehydrogenase Dysfunction in Huntington's Disease
    Naia, Luana
    Cunha-Oliveira, Teresa
    Rodrigues, Joana
    Rosenstock, Tatiana R.
    Oliveira, Ana
    Ribeiro, Marcio
    Carmo, Catarina
    Oliveira-Sousa, Sofia I.
    Duarte, Ana I.
    Hayden, Michael R.
    Cristina Rego, A.
    JOURNAL OF NEUROSCIENCE, 2017, 37 (10) : 2776 - 2794
  • [36] Mitochondrial bioenergetics and dynamics in Huntington's disease: tripartite synapses and selective striatal degeneration
    Oliveira, Jorge M. A.
    JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 2010, 42 (03) : 227 - 234
  • [37] The Metabolic Basis for Nervous System Dysfunction in Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease
    Maiese, Kenneth
    CURRENT NEUROVASCULAR RESEARCH, 2023, 20 (03) : 314 - 333
  • [38] Corticostriatal Dysfunction in Huntington's Disease: The Basics
    Bunner, Kendra D.
    Rebec, George V.
    FRONTIERS IN HUMAN NEUROSCIENCE, 2016, 10
  • [39] Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease
    Franco-Iborra, Sandra
    Vila, Miquel
    Perier, Celine
    FRONTIERS IN NEUROSCIENCE, 2018, 12
  • [40] The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease
    Hastings, Teresa G.
    JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 2009, 41 (06) : 469 - 472